Childhood cancer survival rates in two South African units

David K Stones1, Gerhard P De Bruin, Tonya M Esterhuizen

  • 1Department of Paediatrics and Child Health, Universitas Academic Hospital Complex, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa. stonesDK@ufs.ac.za.

Insights

Childhood cancer survival rates in South Africa were 52.1%, lower than in developed countries. This is due to late diagnosis, highlighting the need for improved cancer awareness strategies.

Area of Science:

  • Pediatric Oncology
  • Cancer Epidemiology
  • Global Health

Background:

  • Childhood cancer cure rates are high globally, but survival varies significantly between developed and developing nations.
  • Survival data for childhood cancers in many African countries remain largely unknown.
  • Significant disparities exist in childhood cancer outcomes worldwide.

Purpose of the Study:

  • To analyze and report on childhood cancer survival rates.
  • To compare outcomes between two major South African pediatric oncology centers.
  • To identify factors influencing survival in South African children with cancer.

Main Methods:

  • Retrospective review of pediatric cancer patients (0-15 years) admitted between 1987 and 2011.
  • Inclusion of data from two South African pediatric oncology units: Universitas Hospital and Tygerberg Hospital.
  • Histological confirmation of all diagnoses and similar treatment protocols across units.

Main Results:

  • Overall survival rate for childhood cancers was 52.1% across 3,241 children.
  • Leukemia (25.0%), brain tumors (19.5%), and lymphoma (13.0%) were the most common malignancies.
  • Lymphoma (63.9%) and nephroblastoma (62.6%) showed the highest survival, while brain tumors had the lowest (46.4%).
  • Survival rates varied by ethnicity: White (62.8%), mixed-race (53.8%), and Black children (48.5%).

Conclusions:

  • South African childhood cancer survival rates are lower than in developed countries, primarily due to advanced disease at presentation.
  • Urgent implementation of new strategies to improve cancer awareness is critical.
  • Addressing late diagnosis is essential to improve pediatric cancer outcomes in South Africa.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
706
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

4.8K